Villamor, Erlinda N.

HRN: 20-49-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/25/2022
07/02/2022
IV
4.5gram As LD
As Loading Dose
Septicemia
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: